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Gene Array and Expression of Mouse Retina Guanylate 
Cyclase Activating Proteins 1 and 2
Kim Howes,1,6 J. Darin Bronson,1'6 Yan Li Dang,2 Ning L i1 Kai Zhang,1 Claudia Ruiz,2 
Bharati Helekar,2 Muriel Lee,5 Lswari Subbaraya,2 Helga Kolb,1 Jeannie Chen,4 5 and  
Wolfgang Baehr1
P u r p o s e .  To identify gene arrangement, chromosomal localization, and expression pattern of mouse 
guanylate cyclase activating proteins GCAP1 and GCAP2, retina-specific Ca2+-binding proteins, and 
photoreceptor guanylate cyclase activators.
M e t h o d s .  The GCAP1 and GCAP2 genes were cloned from genomic libraries and sequenced. The 
chromosomal localization of the GCAP array was determined using fluorescent in situ hybridization. The 
expression of GCAP1 and GCAP2 in mouse retinal tissue was determined by immunocytochemistry.
R e s u l t s .  In this study, the mouse GCAP1 and GCAP2 gene array, its chromosomal localization, RNA 
transcripts, and immunolocalization of the gene products w ere fully characterized. The GCAP 
tail-to-tail array is located at the D band of chromosome 17. Each gene is transcribed into a single 
transcript of 0.8 kb (GCAP1) and 2 kb (GCAP2). Immunocytochemistry showed that both GCAP 
genes are expressed in retinal photoreceptor cells, but GCAP2 was nearly undetectable in cones.
GCAP2 was also found in amacrine and ganglion cells of the inner retina. Light-adapted and 
dark-adapted retinas showed no significant difference in the distribution of the most intense GCAP2 
staining within the outer segment and outer plexiform layers.
C o n c l u s io n s .  Identical GCAP gene structures and the existence of the tail-to-tail gene array in mouse 
and human suggest an ancient gene duplication-inversion event preceding mammalian diversifi­
cation. Identification of both GCAPs in synaptic regions, and of GCAP2 in the inner retina suggest 
roles of these Ca-binding proteins in addition to regulation of phototransduction. (Invest Ophthal­
m ol Vis Sci. 1998;39:867-875)
G uanylate cyclase activating proteins (GCAPs) are 
Ca2+-binding proteins of the calmodulin gene fami­
ly1 that contain four EF hand Ca2+-binding motifs. 
To date, tw o GCAPs (GCAP1 and GCAP2) have been identi-
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fied in mammalian retina.2*6 Both GCAPs activate pho to re­
cep to r guanylate cyclase in the presence of low  [Ca2+], a 
regulatory m echanism  that prom otes accelerated synthesis 
of cGMP, the internal m essenger of phototransduction , after 
photobleaching. The hum an GCAP genes are arranged in a 
com pact tail-to-tail gene array in w hich both  genes are 
transcribed from  opposite strands.7 Biochemical and imm u­
nologic studies to determ ine the cellular and subcellular 
distribution of GCAPs in the retina have produced  conflict­
ing results. RNA expression studies show  nearly identical 
expression patterns of GCAP1 and GCAP2 mRNAs in rod and 
cone pho to recep to rs.5,8,9 Bovine GCAPl was isolated from 
rod ou ter segm ent m em branes,3,10 but GCAP2 could5 or 
could not be isolated6'10 from this source. Im m unocyto­
chem istry using GCAPl-specific antibodies has revealed that 
GCAPl is p resen t in rod and cone outer segm ents and in 
synaptic regions.6 GCAP2 was seen in ou ter and inner seg­
m ents of rods but not of cones by one group of investiga­
to rs.5 It was seen in the inner segm ents of rods and cones 
bu t no t in ou ter segm ents by another group .9 The reasons 
for these discrepancies in GCAP2 distribution are unknow n.
In this study, we characterized the GCAP genes and their 
expression patterns in the retina of the mouse, an animal amena­
ble to genetic manipulation. The ultimate goal of this research 
was to prevent expression of GCAP genes by targeted gene 
replacement (gene knockout) and to analyze the consequences of 
this manipulation on the physiology and morphology of photore­
ceptor cells. As a first step toward this goal, we describe the GCAP
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gene arrangement and chromosomal localization in mouse, and 
discuss expression patterns of both GCAPs in the retina.
M a t e r ia l s  a n d  M e t h o d s  
Clo n in g  o f  M ouse GCAP2 cDNA and  DNA 
S eq u en cin g
Mouse GCAPl cDNA clones were described previously.8 To 
isolate mouse GCAP2 cDNA clones, a mouse retina cDNA 
library was screened with a bovine GCAP2 cDNA insert. Two 
clones w ere isolated, mG2-6 and mG2-7. The inserts of AzapII 
bacteriophage (Invitrogen, San Diego, CA) clones w ere excised 
according to the manufacturer's protocol. Supercoiled plasmid 
DNA was sequenced using the double-stranded procedure de­
scribed previously11 or using an automatic sequencer (LI-COR 
Model 4000L) and universal primers labeled with an infrared 
fluorescent tag. The coding portions of all clones were com­
pletely sequenced on both strands. mG2-6 was 5'-tmncaied in 
exon 1. Clone mG2-7 contained the com plete coding sequence 
but had an extended 5 '-untranslated region (UTR) deviating 
from the gene sequence.
N orthern  Blot A nalysis
Mouse retina mRNA was isolated (Fasttrack; Invitrogen), was 
separated on 0.43 M formaldehyde agarose gels,12 and was trans­
ferred to maximum strength nylon filters (Nytran; Schleicher and 
Schuell), as described previously.4,13 The GCAPl probe was 
mGl-4, the GCAP2 probe mG2-6 (Pig. 1). The mouse opsin cDNA 
probe used as a control has been described previously.14
M ouse GCAP G enom ic C lon es
A nick-translated GCAPl fragment was used to screen a mouse 
genomic library (mouse 129SVJ strain, prepared from liver of a 
4 -8-week-old female; Stratagene, La Jolla, CA). Three genomic 
clones (AMG1, \MG2, and A.MG3) with inserts of 15 to 18 kb were 
identified and characterized by subcloning. £coRJ fragments of 
AMG2 corresponded to the two major GCAPl genomic fragments 
seen on Southern blots,8 and were subcloned into pUC13 to yield 
pUC-bot and pUC-top (Fig. 2). Puc-bot and pUC-top contained 
introns b and c and most of intron a of the GCAPl gene. The 
remainder of intron a was amplified with sequence-specific prim­
ers. Introns of die GCAP2 gene were amplified from genomic 
DNA with exon-specific primers (Fig. 2), using either Taq poly­
merase according to the Cctus (Berkeley. CA)/Perkin-Elmcr (Nor­
walk, CT) protocol, or Taq/Vwo polymerases (Expand long PCR 
system, Boehringer-Mannheim, Indianapolis, IN), and cloned into 
PCRII (Invitrogen).
A ntibod ies
Polyclonal antibody UW14 was raised against bacterially ex­
pressed, tm ncated bovine GCAPl.6 Polyclonal UW50 was 
raised against bovine GCAP2 expressed in bacteria.9 The anti­
human growth hormone antibody (anti-hGH) was character­
ized previously.15
C h rom osom al L ocalization by F luorescent In Situ 
H ybridization
DNA from clone AMG1 was labeled w ith bio-16-dUTP (Boc- 
hringer-M annheim ) by nick translation and hybridized to 







Figiirk 1. Northern blot of normal adult mouse retina mRNA 
probed with GCAP (guanylate cyclase activating protein) 1 and 
GCAP2. Two micrograms of retina mRNA were loaded. Lane 1, 
the blot was probed with mouse GCAPl. Lane 2, the blot was 
stripped and reprobed with mouse GCAP2. Lane 3, stripped 
and reprobed with mouse opsin (mOPS) cDNA as a control. 
The mOPS gene is transcribed into five mRNA species differing 
in polyadenylation sites.14 Known size standards are indicated 
on the right in kilobases.
cells as described.16 Hybridization signals w ere detected 
w ith successive layers o f avidin Texas red (Vector Labora­
tories, Burlingame CA), biotinylated antiavidin (Vector), and 
avidin Texas Red. The initial localization was confirmed by 
using a mouse chrom osom e 17 paint (Cambio, La Jolla, CA).
Im m u n ocytoch em istry
Normal C57BL/6 and transgcnic mice of both sexes w ere killed 
under normal illumination. For dark-adapted experiments, 
three females of one litter were killed at night (12 midnight) 
under red light after 6 hours of dark adaptation. Once the eyes 
were removed, an incision was made through the anterior 
cham ber to facilitate fixation in 4% paraformaldehyde in 0.1 M 
phosphate buffer (PB; pH 7.4). After fixation for 6 hours at 4“C, 
the lenses were removed, and the eyes were rinsed and cryo- 
protected in 30% buffered sucrose overnight at 4CC. Eight- 
micrometer-thick cryoscctions were incubated in 10% normal 
goat serum for 30 minutes to inhibit nonspecific binding of the 
antibodies. In some cases, the tissue sections were also perme- 
abilized with 0.1 mg/ml proteinase K for 2 minutes before 
blocking with normal goat scrum. Primary and secondary an­
tibodies w ere diluted with 0.1 M PB and 0.3% Triton X-100 for 
all reactions. Sections were rinsed with 0.1 M PB after each 
incubation. Sections were incubated overnight at 4°C with 
1:2000 UW50 and 1:3000 UW14 antibodies. Fluorescein iso- 
thiocyanate (FITC) or Texas red-conjugated goat antirabbit 
IgG (Vector) was used at a dilution of 1:100 for 1 hour at room
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F ig u r e  2 .  Physical map of mouse cDNA and genomic clones, and diagram of the GCAP 
(guanylate cyclase activating protein) 2-GCAP1 gene array. The 5'-UTRs of the GCAP2 (left) 
and GCAP1 (right) genes are flanking the gene array, which is depicted as an 18-kb contig. 
Exons are shown as boxes; the coding portions are filled. Introns (length in kilobases) and 
flanking sequences are shown as lines. Boxes within introns depict dinucleotide repeats of 
various lengths. EcoBl restriction sites identified in the gene sequence and cloned fragments 
(pUC-bot, pUC-top) are shown. Bars underneath and above the exons indicate the extent of 
cloned cDNA for both genes (mGCAPI, clones m G l-4 , and m G l-2; and mGCAP2, clones 
mG2-6 and mG2-7, respectively). Lines under the GCAP2 gene marked by a, b, and c symbolize 
intron clones generated by amplification with exon-specific primers. Large arrow s indicate 
the direction of transcription. AMG1, AMG2, and AMG3 are genomic AfixII clones. Vertical 
broken lines identify their starting and ending points, if known, determ ined by direct 
sequencing of ADNA (for details, see the Genbank submission).
temperature. For double-labeling experiments, sections were 
processed by one of tw o methods. In the first, sections were 
incubated with 10 fxg/ml F1TC- or Texas red-peanut agglutinin
(PNA; Sigma, St. Louis, MO) and UW50 or UW14 antibodies, 
then by FITC- conjugated or Texas red-conjugated goat anti­
rabbit IgG. In the second method, sections were sequentially
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F i g u r e  3- Chromosomal localization of the GCAP (guanylate cyclase activating protein) gene 
array. (A) Localization of the GCAP gene array by fluorescent in situ hybridization to chrom o­
some 17. (B) Ideogram of chromosome 17 and location of the gene array at 17D.
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F ig u re  4. Immunolocalization of GCAPl in normal and transgenic human growth hormone 
(hGH) mice, (a) GC.AP (guanylate cyclase activating protein) I signal is most intense within the 
outer segments o f rods and cones and in the outer plexiform layer, (b) Colocalization of Texas 
red-labeled GCAPl with fluorescein isothiocyanale (F1TC)-conjugated peanut agglutinin for 
cones (note the yellow signal obtained in the outer segments of cones), (c) FITC-labeled 
GCAP1 outer segments are contiguous with inner segments of blue cones (Texas red) detected 
with the hGH antibody in transgenic mouse sections, (d) Preincubation of the GCAP1-specific 
antibody UW14 with 25 M.g/ml of GCAPl protein results in loss of outer segment and outer 
plexiform layer staining. Only staining of cones with FITC-conjugated peanut agglutinin is 
observed Scale bars, 12.5 /xm.
incubated with the hGH primary antibody, and die goat anti­
rabbit secondary antibody and then the UW14 or UW50 pri­
mary antibody and fluorochrome-conjugated goat antirabbit 
secondary antibody. Immunofluorescence was photographed 
with an inverted laser scanning confocal microscope (T-SM410; 
Carl Zeiss, Oberkochen, Germany).
Results
G C A P l a n d  GCAP2 m R NA
All GCAPl and GCAP2 clones were truncated at the 5'-lJTK, 
the 3 'TjTR, or both. None contained a polyA tail, and only 
mouse GCAPl appeared to be alternatively spliced at very low 
levels." Northern blots of mouse retina mRNA revealed single 
transcripts of 0.8 kb (GCAPl) and 2 kb (GCAP2; Fig. I) The 
open reading frames of the GCAPl and GCAP2 mRNA predict 
polypeptides of nearly identical size (202 and 201 amino acids, 
respectively) and identical domain structure (see Fig. 7). The 
predicted polypeptide sequences are very similar (90%) to
those of corresponding human and bovine GCAPs (Fig. 7 and 
Discussion section).
T a il-to -T a il GCAP G e n e  A rra y
To elucidate the gene arrangement in the mouse, we isolated 
diree overlapping genomic clones AMG1, AMG2, and AMG3 (Fig. 
2). Subcloning of genomic £coRl fragments, polymerase chain 
reaction amplification of the intergenic region, and direct se­
quencing showed that the tail-to-tail gene array is preserved in the 
mouse and diat AMG3 contained die entire GCAPl gene, whereas 
AMG1 and AMG2 contained the GCAP2 gene and only portions of 
the GCAPl gene (Fig. 2). The GCAPl and GCAP2 coding regions 
were each interrupted by three introns whose respective posi­
tions were identical (Figs 2, 7). The sizes of the introns varied, 
ranging from 3.5 kb to 280 bp, and no sequence similarity was 
found among corresponding introns of die two genes. Transcrip­
tion start points of the GCAP genes have not been determined, 
but the size of the mRNA for GCAPl (800 bp) would predict 
transcription start and polyadenylation sites witliin 100 bp of die 
borders of the coding region of this gene. No consensus polyad-





Figure 5. Imnumolocalization of GCAP (guanylate cyclase activating protein) 2 in retinal 
sections from normal and transgenic human growth hormone (hGH) mice, (a) GCAP2 staining 
is delectable in outer segments, inner segments, and soma of photoreceptors; the outer 
plexiform layer; amacrine cells (a) of the inner nuclear layer; and ganglion cells, (b) Proteinase 
K treatment produces a staining pattern identical with that shown in (a) for all layers, with an 
increase in intensity of staining of the signal within the inner segments of photoreceptors, (c) 
GCAP2 immunostaining is indicated by fluorescein isothiocyanate (FITQ staining of the outer 
and inner segments of rods, rod soma, and synaptic termini. Weak double-staining of cones 
with Texas red-conjugated peanut agglutinin indicates the presence of GCAP2. (d), blue cone 
soma and inner segments labeled with Texas Red also show a relatively weak continuation of 
labeling of the outer segments with GCAP2 (FITC). (e) lower magnification of c. Scale bars, 
12.5 nm. BC, bipolar cell; CS, cone somata.
envlation signals could be identified close to the translation stop 
codons of either gene, but AATAAA signals17 arc present farther 
downstream. Thus, the presence of untranslated exons in die 
3'-UTR cannot be excluded. The distance between the translation 
stop codons of the two mouse GCAP genes is 2.65 kb, approxi­
mately one half of die intergenic distance (4.5 kb) observed in 
human.7
The GCAP Array Is Located o n  M ouse  
C h ro m o so m e 17
We predicted by synteny with human chromosome structure, 
that the mouse GCAPl gene should be located on chromosome
17. To verify the location of the GCAP gene array, we used 
biotinylatcd AMG3 as a probe for fluorescent in situ hybridiza­
tion (FISH) studies of mouse chromosomes. The initial local­
ization to chromosome 17 was made on 4,6-diamidino-2-phc- 
nylindolc (D/\PI)- banded chromosomes and was confirmed 
using mouse chromosome 17 paint (Fig. 3). No significant
labeling was observed on other chromosomes, indicating ab­
sence of pseudogenes or other closely related GCAP genes, a 
result consistent with those obtained by fluorescent in situ 
hybridization in human chromosomes.
Im m u n o loca liza tion  o f  GCAPl
We performed immunocytochemical itnaiyses using monospe­
cific antibodies for GCAP 1 and GCAP2 in sections of normal 
mouse retina, in combination with fluorochrome-conjugated PNA 
to identify cones. To distinguish among cone types, we also 
analyzed sections of transgenic mouse retinas that express hGH 
specifically in blue cones and bipolar cells.15 For GCAPl immu- 
nolocalization, we used UW14, a monospecific polyclonal anti­
body raised against bacterially expressed GCAP 6 When applied to 
sections from normal mouse retina, the most intense response 
was seen in the outer segments and synaptic termini of rods and 
cones (Fig. 4a), a distribution consistent with that reported earlier 
in the bovine retina/’ The signal was completely abolished by
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F ig u r e  6 .  Immunocytochemical localization of GCAP (guanylate cyclase activating protein) 2 
in dark-adapted (a) versus light-adapted (b) mice. Color-enhanced fluorescein-labeled section 
superimposed on the bright-field background. Predominant staining for GCAP2 resides within 
outer segments and the outer plexiform layer for light- and dark-adapted mice. A slight increase 
in GCAP2 signal is visible in the inner segment and outer nuclear layer of dark-adapted mouse 
retinas. Bar, 25 /xm. IS, inner segment; OS, outer segments; ONL, outer nuclear layer; OPL, 
outer plexiform layer.
preabsorption of the UW14 antibody with 25 Mg/ml bovine 
GCAPl (Fig. 4d). Sections double stained with PNA (FITC) and 
GCAPl (Texas red) revealed the presence of numerous cone 
photoreceptors, the outer segments of which were double 
stained (Fig. 4b). When transgenic retinas expressing hGH were 
double labeled with UW14 and anti-hGH antibody, blue cone 
inner segments were positive for hGH, blue cone outer segments 
for GCAPl, and rods for only GCAPl (Fig. 4c). As expected, 
bipolar cells were stained only with hGH. The results show that 
GCAPl is present at high levels in mouse rod and cone outer 
segments in agreement with results in bovine.6
Immunolocalization of GCAP2
For GCAP2 localization experim ents, we used a m onospe­
cific polyclonal antibody raised against bacterially expressed 
GCAP2.9 In normal adult m ouse retinas, GCAP2 responses 
w ere seen in the ou ter segm ents and, to a lesser extent, in 
the inner segments of rods and in the synaptic terminals 
(Fig. 5a). Pretreatm ent of sections w ith proteinase K re­
sulted in a substantial increase in GCAP2 immunolabeling 
only in the inner segments (Fig. 5b). Proteinase K treatm ent 
did not alter GCAPl or hGH staining (data not shown). The 
intensity of GCAP2 staining of the rod inner segm ent was 
m uch stronger than that observed in GCAPl (Fig. 4a). In 
addition, imm unostaining was seen in the inner retina in 
am acrine and ganglion cell types (but not in bipolar cells), 
w hereas GCAPl staining had been limited to photoreceptors
(Fig. 4a). W hen cones w ere double labeled with PNA (Texas 
red) and UW50 (F1TC), only relatively weak GCAP2 immu­
nostaining was detected in cone ou ter and inner segm ents 
(Figs. 5c, 5c). Blue cones, specifically identified with anti- 
hGH antibody, also only weakly costained with UW50 (Fig. 
5d). In monkey and human, GCAP2 was strongly detected  by 
inim unocytocheniistry in cone inner segm ents.,J In bovine, 
GCAP2 staining of the cone inner segm ents is less evident 
than that seen in monkey and human.
L ig h t—D a rk  D e p e n d e n c e  o f  G CA P2 S ta in in g
W hen GCAP2 staining was perform ed in parallel w ith light- 
and dark-adapted retinas (Fig. 6), no significant differences 
w ere observed in regard to  predom inant staining for GCAP2 
in the outer segm ents o f rods and the ou ter plexiform layer. 
The only differences are a slight increase in GCAP2 staining 
in the inner segment region as well as in the ou ter nuclear 
layer of dark-adapted mice, possibly indicating a replenish­
m ent mechanism for GCAP2 during the scotophase. We 
conclude that in mouse, GCAP2 staining is strong in rods, 
including synaptic termini, but is nearly undetectable in 
cones. In contrast to GCAPl, GCAP2 can also be detected  in 
the inner retina, particularly in am acrine and ganglion cells 
in which its function is unknow n. There is no significant 
effect of light- dark adaptation on the apparent distribution 
o f GCAP2 in the mouse retina.
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F ig u r e  7 .  Alignment of GCAP (guanylate cyclase activating protein) 1 and GCAP2 amino acid 
sequences from various species. The sequences were divided into two subgroups, GCAPl and 
GCAP2. In the GCAPl subgroup, the mouse GCAPl sequence8 was aligned with GCAPl sequences 
from bovine, human, frog,4 and chicken.20 In the GCAP2 subgroup, the mouse GCAP2 sequence 
was aligned with the GCAP2 sequences from human,7 bovine,6 and chicken.20 L=I=V=M; Y=F; 
E=D; R=K; A=T=S are considered conservative substitutions. For best fit, several gaps were 
introduced (shown by hyphens'). Residues conserved in all GCAP sequences are shown on black 
background. Residues identical in only one of the groups are lightly shaded. Predicted EF hand 
Ca2+-binding domains (EF2-EF4) are boxed, EF1 (presumably not functional for Ca2+-binding) is 
boxed by a broken line. The identical positions of introns a -c  in mouse, human, and bovine 
GCAPs are shown by triangles above the alignments. Domains conserved in all GCAPs shown are 
identified by a shaded bar above the alignment (CD1-CD3), and variable domains are shown by 
VD1-VD4. A dendrogram (PC-GENE, IntelliGenetics; Mountain View, CA) calculated on the basis 
of the amino acid sequences is shown at the top left.
D i s c u s s io n
GCAPs are m em bers of a subfamily of Ca2+-binding proteins 
belonging to the large superfamily of calmodulin-like Ca2+- 
binding p ro te in s ,18 w hich characteristically contain four EF 
hand h e lix -lo o p -h e lix  m otifs.19 Five GCAPl and GCAP2 
genes- cDNA have been cloned to date from various verte­
brate species.4 -6,8,20 A consensus is em erging concerning 
conserved and variable domains and concerning domains 
involved in m em brane association and GC stimulation. Vari­
able domains include the N- and C-terminal ends and spacer 
domains betw een  EF1-EF2 and EF3-EF4 (Fig. 7). Function­
ally indispensable domains include regions surrounding the 
four EF hand motifs. The exact stoichiom etry of bound 
Ca2+/M r;rA P  has not been determ ined, but EF1 is thought 
to be nonfunctional, w hereas EF2, EF3 and EF4 conform  to 
the EF hand consensus sequence and m ost likely are fully 
functional.1 Inactivation of EF hand Ca2+-binding domains
in GCAP2 by m utagenesis produces a constitutive activator 
of GC lacking Ca24- sensitivity.21 Similar effects have been 
seen w ith m utant GCAPl.22 For GCAPl w e also show ed that 
the N-terminal domain, although variant in the GCAPs, is 
indispensable for GC stim ulation and m em brane associa­
tion.23 All GCAPs appear to be myristoylated at the N ter­
m inus of the processed proteins (Gly-2; Fig. 7). The fatty 
acid side chain, how ever, is not directly involved in mem ­
brane association, because a GCAPl-G2A m utant, in w hich 
the myr anchor Gly-2 was replaced by Ala, sedim ents w ith 
rod outer segm ent m em branes.23 M embrane association of 
GCAPl was only abolished w hen  the N-terminal 25 amino 
acids w ere deleted, a dom ain that does not contain an 
obvious m otif for pro tein-m em brane interaction.
In the present study, we attem pted to identify the cell 
types and the subcellular com partments of cells expressing 
GCAPs in the mouse retina. The mouse retina has no fovea, but
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it contains a substantial num ber of cones (3%-9% of all photo­
receptors).24,25 The cones can be identified, among other tech­
niques, by staining with peanut agglutinin.26 Our study shows 
apparent distribution of GCAP2 mostly in rods and certain cell 
types of the inner retina but near absence of GCAP2 in cones. 
In bovine retina,9 the GCAP2 signal is generally more intense in 
the inner segments of rods and is weaker in cones, but in 
monkey and human retinas, the GCAP2 signal is more intense 
in cone inner segments and is much weaker in rods. The 
reason for this apparent discrepancy among species is un­
known. The specificity of the antibodies used in this study was 
examined by early experiments in which a com plete loss of 
immunocytochemical signal in the mouse retina occurred 
when UW14 and UW50 antibodies were preabsorbed with 
bovine GCAPl and GCAP2 proteins, respectively (data not 
shown). One possible reason for the discrepancy in GCAP2 
staining among species could be the partial masking of the 
epitope recognized by the anti-GCAP2 antibody UW50. To 
investigate this possibility, mouse retina sections were sub­
jected to limited proteinase K treatm ent before immunocyto­
chemistry. GCAP2 staining in inner segments of rods was 
substantially increased (compare Fig. 5A with 5B), consistent 
w ith partial removal of masking protein antigens. Limited pro­
teolysis, however, did not significantly improve GCAP2 stain­
ing in mouse cones. Furthermore, comparison of dark- and 
light-adapted mouse retinas did not reveal significant differ­
ences in GCAP2 distribution. Based on these results and re­
ports by others on GCAP2 distribution in other animals, we 
conclude that there is an apparent species-dependent variation 
of GCAP2 levels in cones.
In contrast to m ost o ther calmodulin-like Ca2+-binding 
proteins, the function of GCAPs has been unam biguously 
established: Both GCAPs stimulate pho to recep to r GC in low 
free [Ca2+].' Im portant questions that remain concern  the 
specific roles that GCAPs play in regulating the function of 
pho to recep to rs and in pathways unrelated to photo trans­
duction in pho to recep to rs o r in o ther retinal cells. Common 
to both  GCAPs is their p resence in the synaptic region of 
photoreceptors, a region rem ote from phototransduction. 
cGMP-gated channels have been observed in these subcel- 
lular com partm ents, w hich suggests that a GC-GCAP system 
unrelated to phototransduction  may exist in synaptic term i­
nals of photorecep tors. A major difference is the p resence of 
GCAP2 and absence of GCAPl in the inner retina, particu­
larly in am acrine and ganglion cells. The function of GCAP2 
in the inner retina, or the pathways in w hich it participates, 
are unknown.
Distinct cellular or subcellular expression of GCAPs would 
be consistent with the tail-to-tail arrangements of their genes. 
Such arrangements of related genes occur in a variety of mam­
malian genes.7 Gene duplication mechanisms that lead to tail- 
to-tail orientations require an inversion in addition to nonho- 
mologous breakage. The consequence of inversion is that the 
5' regulatory elements governing tissue specificity are located 
on opposite ends of the gene arrangement, thus allowing for 
divergent evolution and differential tissue or subcellular ex­
pression. The presence of GCAP tail-to-tail arrangements in 
human and mouse suggests that the GCAP duplication-inver- 
sion event occurred before mammalian diversification, more 
than 300 million years ago.
Based on the tail-to-tail gene arrangement and similar ex­
pression patterns of the GCAPs, we conclude that the mouse
will provide a unique model for genetic manipulation. The 
gene array will allow for double-knockout constructs, and the 
consequence of absence of both GCAPs on retinal develop­
m ent and function can be examined. In addition, single knock­
outs will answer the question of w hether the GCAPs provide 
redundant or unique functions in photoreceptor cells. Eventu­
ally, genetically altered mouse models will most likely resolve 
unanswered questions on localization and function of GCAPs 
in the retina.
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